Secondary Logo

Journal Logo

April 2000 - Volume 23 - Issue 2
pp: 5A-5A,107-213


Toxicity and Activity of Docetaxel in Anthracycline-Pretreated Breast Cancer Patients: A Phase II Study

Ferraresi, Virginia; Milella, Michele; Vaccaro, Angela; More

American Journal of Clinical Oncology. 23(2):132-139, April 2000.

Randomized Comparison of Prophylactic Antidiarrheal Treatment Versus No Prophylactic Antidiarrheal Treatment in Patients Receiving CPT-11 (Irinotecan) for Advanced 5-FU-Resistant Colorectal Cancer: An Open-Label Multicenter Phase II Study

Ychou, Marc; Douillard, Jean Yves; Rougier, Philippe; More

American Journal of Clinical Oncology. 23(2):143-148, April 2000.

Uninterrupted Moderately Accelerated Radiotherapy in the Treatment of Unresectable/Advanced Head and Neck Cancer: One Institution’s Experience and a Comparative Review

Dowlatshahi, Morteza; Iganej, Shahrokh; Ciabatone, Antonella; More

American Journal of Clinical Oncology. 23(2):149-154, April 2000.

Comparative Efficacy of Three 5-HT3 Antagonists (Granisetron, Ondansetron, and Tropisetron) Plus Dexamethasone for the Prevention of Cisplatin-Induced Acute Emesis: A Randomized Crossover Study

Chua, Daniel T. T.; Sham, Jonathan S. T.; Kwong, Dora L. W.; More

American Journal of Clinical Oncology. 23(2):185-191, April 2000.

A Phase II Study of Combined Chemoradiotherapy for Limited Disease–Small-Cell Lung Cancer

Ishihara, Shinichi; Tsuchiya, Satoshi; Minato, Koichi; More

American Journal of Clinical Oncology. 23(2):197-202, April 2000.


Show: